Marie Faughnan

Dr. Marie E Faughnan, MD

Claim this profile

St. Michael's Hospital

Studies Hereditary Hemorrhagic Telangiectasia (HHT)
Studies Osler-Weber-Rendu Syndrome
5 reported clinical trials
5 drugs studied

Area of expertise

1

Hereditary Hemorrhagic Telangiectasia (HHT)

Marie E Faughnan, MD has run 5 trials for Hereditary Hemorrhagic Telangiectasia (HHT). Some of their research focus areas include:

ENG positive
SMAD4 positive
ALK positive
2

Osler-Weber-Rendu Syndrome

Marie E Faughnan, MD has run 5 trials for Osler-Weber-Rendu Syndrome. Some of their research focus areas include:

ENG positive
SMAD4 positive
ALK positive

Affiliated Hospitals

Image of trial facility.

St. Michael's Hospital

More about Marie E Faughnan, MD

Clinical Trial Related

5 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 0 Active Clinical Trials

Treatments Marie E Faughnan, MD has experience with

  • Registry Participation
  • Tacrolimus
  • Sirolimus
  • Doxycycline Hyclate
  • Placebo

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Marie E Faughnan, MD specialize in?

Is Marie E Faughnan, MD currently recruiting for clinical trials?

Are there any treatments that Marie E Faughnan, MD has studied deeply?

What is the best way to schedule an appointment with Marie E Faughnan, MD?

What is the office address of Marie E Faughnan, MD?

Is there any support for travel costs?